Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Christopher Nieset"'
Autor:
Smeet Gala, Christopher Nieset, Mkaya Mwamburi, M Nanavaty, Yair Levy, Lisa J. McGarry, Edward J. Pearson
Publikováno v:
Leukemia Research. 43:1-8
Treatment of newly-diagnosed patients with chronic-phase chronic myeloid leukemia (CP-CML) with tyrosine kinase inhibitors (TKIs) results in near-normal life expectancy. However, CP-CML patients resistant to initial TKIs face a poorer prognosis and s
Autor:
Catherine R. Taylor, Shibani Pokras, J. Munakata, Victoria Divino, Y.J. Chen, Lisa J. McGarry, Hui Huang, Elias Jabbour, Christopher Nieset, Daniel C. Malone
Publikováno v:
Current medical research and opinion. 32(2)
To assess the economic burden of tyrosine kinase inhibitor (TKI) treatment failure in chronic myeloid leukemia (CML), by assessing all-cause health care resource use (HCRU) and costs in the year after treatment failure by line of therapy (LOT; 1L/2L/
Autor:
Catherine R. Taylor, Hui Huang, Shibani Pokras, Y.J. Chen, Lisa J. McGarry, Victoria Divino, Daniel Ng, Christopher Nieset, J. Munakata, Kevin B. Knopf
Publikováno v:
Clinical lymphoma, myelomaleukemia. 15(11)
Background The economic burden of tyrosine kinase inhibitor (TKI) treatment failure in chronic myeloid leukemia (CML) is not well understood. The objective of this study was to quantify the economic burden associated with treatment failure versus suc
Autor:
Victoria Divino, Y.J. Chen, Hui Huang, Catherine R. Taylor, Shibani Pokras, J. Munakata, Shawn Hallinan, Daniel Ng, Lisa J. McGarry, Christopher Nieset, Daniel C. Malone
Publikováno v:
Value in Health. 17(3):A78-A79